Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

BACKGROUND: CD73 is an ecto-enzyme that promotes tumor immune escape through the production of immunosuppressive extracellular adenosine in the tumor microenvironment. Several CD73 inhibitors and adenosine receptor antagonists are being evaluated in phase I clinical trials. PATIENTS AND METHODS: Ful...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Oncol
Main Authors: Buisseret, L, Pommey, S, Allard, B, Garaud, S, Bergeron, M, Cousineau, I, Ameye, L, Bareche, Y, Paesmans, M, Crown, J P A, Di Leo, A, Loi, S, Piccart-Gebhart, M, Willard-Gallo, K, Sotiriou, C, Stagg, J
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Original articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913595/
https://ncbi.nlm.nih.gov/pubmed/29145561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx730
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares